loading
Schlusskurs vom Vortag:
$1.40
Offen:
$1.41
24-Stunden-Volumen:
206.54K
Relative Volume:
1.34
Marktkapitalisierung:
$24.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.29M
KGV:
-2.0286
EPS:
-0.7
Netto-Cashflow:
$-6.47M
1W Leistung:
+1.07%
1M Leistung:
-6.91%
6M Leistung:
-1.05%
1J Leistung:
-23.51%
1-Tages-Spanne:
Value
$1.3804
$1.43
1-Wochen-Bereich:
Value
$1.15
$1.46
52-Wochen-Spanne:
Value
$0.94
$2.55

NanoViricides Inc Stock (NNVC) Company Profile

Name
Firmenname
NanoViricides Inc
Name
Telefon
203-937-6137
Name
Adresse
1 Controls Drive, Shelton, CT
Name
Mitarbeiter
7
Name
Twitter
@nnvcnyse
Name
Nächster Verdiensttermin
2025-05-20
Name
Neueste SEC-Einreichungen
Name
NNVC's Discussions on Twitter

Vergleichen Sie NNVC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NNVC
NanoViricides Inc
1.415 24.59M 0 -8.29M -6.47M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.89 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
543.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
319.51 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
559.00 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.56 28.51B 3.81B -644.79M -669.77M -6.24

NanoViricides Inc Stock (NNVC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2015-02-11 Eingeleitet Midtown Partners Strong Buy

NanoViricides Inc Aktie (NNVC) Neueste Nachrichten

pulisher
Jun 18, 2025

With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides' Dr. Diwan - Knoxville News Sentinel

Jun 18, 2025
pulisher
Jun 18, 2025

NanoViricides' NV-387 Emerges as a Promising Broad-Spectrum Antiviral Against COVID-19 and Bird Flu - citybuzz -

Jun 18, 2025
pulisher
Jun 18, 2025

Small cap wrap: Fineqia, NanoViricides, Standard Uranium... - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

NanoViricides touts antiviral NV-387 as tool against new COVID variant - Proactive financial news

Jun 18, 2025
pulisher
Jun 10, 2025

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in AfricaPhase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu - The Columbus Dispatch

Jun 10, 2025
pulisher
Jun 05, 2025

NanoViricides Advances Measles Drug Program as Global Outbreaks Rise - citybuzz -

Jun 05, 2025
pulisher
Jun 04, 2025

NanoViricides Measles Drug Development Animal Study is Imminent - Akron Beacon Journal

Jun 04, 2025
pulisher
Jun 04, 2025

Small cap wrap: NanoViricides, New Era Helium, Charbone Hydrogen, Voyageur Pharmaceuticals... - Proactive Investors

Jun 04, 2025
pulisher
Jun 04, 2025

NanoViricides commissions animal study of broad-spectrum antiviral for measles - Proactive Investors

Jun 04, 2025
pulisher
Jun 04, 2025

NanoViricides (NNVC) Advances Measles Drug Development | NNVC St - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Breakthrough Measles Drug Enters Critical Testing Phase as Global Cases Surge 10X - Stock Titan

Jun 04, 2025
pulisher
Jun 02, 2025

Nanoviricides (NNVC) To Unveil 'Escape-Proof' Antiviral Platform At Major Biotech Convention - MENAFN.com

Jun 02, 2025
pulisher
Jun 02, 2025

NanoViricides (NNVC) to Unveil 'Escape-Proof' Antiviral Platform at Major Biotech Convention - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Gold Is Bullish, But Be Aware Of Deeper Intraday Pullback; Elliott Wave Intraday Analysis - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

NanoViricides (NNVC) to Unveil ‘Escape-Proof’ Antiviral Platform at Major Biotech Convention - The Globe and Mail

Jun 02, 2025
pulisher
May 28, 2025

NanoViricides to Present at the BIO International Convention in Boston on Monday, June 16, 2025 - Lohud

May 28, 2025
pulisher
May 28, 2025

NanoViricides to Showcase Breakthrough Antiviral Platform at BIO International Convention - citybuzz -

May 28, 2025
pulisher
May 28, 2025

Hudbay Receives TSX Approval for Normal Course Issuer Bid - The Globe and Mail

May 28, 2025
pulisher
May 28, 2025

NanoViricides to present at BIO International Convention 2025 in Boston - Proactive financial news

May 28, 2025
pulisher
May 22, 2025

NanoViricides president backs FDA's targeted COVID booster policy shift - Proactive financial news

May 22, 2025
pulisher
May 22, 2025

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan - ACCESS Newswire

May 22, 2025
pulisher
May 17, 2025

Small cap wrap: NanoViricides, Trust Stamp, NextSource, StickIt... - Proactive financial news

May 17, 2025
pulisher
May 16, 2025

NanoViricides advances NV-387 antiviral program, eyes Phase II trials for Mpox - Proactive Investors

May 16, 2025
pulisher
May 16, 2025

NanoViricides: MPox ethics approval enables Phase 2 application - Proactive Investors

May 16, 2025
pulisher
May 16, 2025

NanoViricides: Fiscal Q3 Earnings Snapshot - Huron Daily Tribune

May 16, 2025
pulisher
May 15, 2025

Small cap wrap: atai, Black Swan Graphene, TNR Gold, NanoViricides... - Proactive financial news

May 15, 2025
pulisher
May 14, 2025

NanoViricides progresses antiviral portfolio as measles and MPox threats rise - Proactive financial news

May 14, 2025
pulisher
May 14, 2025

Measles Cases Are Increasing Globally; MPox Continues to Be a ThreatBroad-Spectrum Antiviral Drug Could Be the Solution - The Derrick

May 14, 2025
pulisher
May 13, 2025

AMAT Likely to Beat Q2 Earnings Estimates: How to Play the Stock - The Globe and Mail

May 13, 2025
pulisher
May 08, 2025

Small cap wrap: NanoViricides, Alvopetro, Polarean... - Proactive financial news

May 08, 2025
pulisher
May 08, 2025

NanoViricides wins ethics approval for Phase II Mpox drug trial in DRC - Proactive financial news

May 08, 2025
pulisher
May 08, 2025

Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo - The Derrick

May 08, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Buys 30,800 Shares of NanoViricides, Inc. (NYSE:NNVC) - Defense World

May 07, 2025

Finanzdaten der NanoViricides Inc-Aktie (NNVC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.91
price up icon 1.21%
$36.18
price up icon 0.58%
$20.72
price down icon 2.91%
$99.33
price down icon 1.11%
$107.07
price up icon 0.55%
biotechnology ONC
$242.60
price up icon 0.07%
Kapitalisierung:     |  Volumen (24h):